264 related articles for article (PubMed ID: 6813430)
1. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
Glew RH; Daniels LB; Clark LS; Hoyer SW
J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
[TBL] [Abstract][Full Text] [Related]
2. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
[TBL] [Abstract][Full Text] [Related]
3. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
Garrett KO; Prence EM; Glew RH
Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
[TBL] [Abstract][Full Text] [Related]
4. Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.
Basu A; Glew RH; Daniels LB; Clark LS
J Biol Chem; 1984 Feb; 259(3):1714-9. PubMed ID: 6693432
[TBL] [Abstract][Full Text] [Related]
5. Brain glucocerebrosidase in Gaucher's disease.
Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
[TBL] [Abstract][Full Text] [Related]
6. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
Choy FY; Davidson RG
Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
[TBL] [Abstract][Full Text] [Related]
8. A case of nonneurologic Gaucher's disease that biochemically resembles the neurologic types.
Glew RH; Gopalan V; Hubbell CA; Beutler E; Geil JD; Lee RE
J Neuropathol Exp Neurol; 1991 Mar; 50(2):108-17. PubMed ID: 1672707
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
Owada M; Sakiyama T; Kitagawa T
Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
[TBL] [Abstract][Full Text] [Related]
10. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
Choy FY
Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
[TBL] [Abstract][Full Text] [Related]
12. Multiple forms of membrane-bound beta-glucosidase in Gaucher's disease.
Yaqoob M; Carroll M
Clin Genet; 1981 Aug; 20(2):161-7. PubMed ID: 6796311
[TBL] [Abstract][Full Text] [Related]
13. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
Prence EM; Garrett KO; Panitch H; Basu A; Glew RH; Wherrett JR; Huterer S
Clin Chim Acta; 1986 Apr; 156(2):179-89. PubMed ID: 3085988
[TBL] [Abstract][Full Text] [Related]
14. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
Maret A; Salvayre R; Nègre A; Douste-Blazy L
Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
[TBL] [Abstract][Full Text] [Related]
15. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
Gonzales ML; Basu A; de Haas GH; Dijkman R; van Oort MG; Okolo AA; Glew RH
Arch Biochem Biophys; 1988 Apr; 262(1):345-53. PubMed ID: 3355173
[TBL] [Abstract][Full Text] [Related]
16. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
[TBL] [Abstract][Full Text] [Related]
17. Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease.
Wenger DA; Clark C; Sattler M; Wharton C
Clin Genet; 1978 Feb; 13(2):145-53. PubMed ID: 23912
[TBL] [Abstract][Full Text] [Related]
18. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
[TBL] [Abstract][Full Text] [Related]
19. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
Butterworth J; Broadhead DM
Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
[TBL] [Abstract][Full Text] [Related]
20. Identity of 'acid' beta-glucosidase and glucocerebrosidase in human spleen.
Ho MW
Biochem J; 1973 Nov; 136(3):721-9. PubMed ID: 4780697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
